Stability testing for applications for variations to a marketing authorisation for veterinary medicinal products - Scientific guideline
Guideline on stability testing for applications for variations to a marketing authorisation for veterinary medicinal products
Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation: 23/02/1998, Revision: 42, Status: Authorised
Concept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling
List of eligible industry stakeholder organisations
Minutes of the CAT meeting 14-16 February 2024
Committee for Advanced Therapies (CAT): 14-16 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 14 February 2024 to 16 February 2024
CAT meetings in 2025 and 2026
Resources for healthcare professionals
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 April 2024